Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro

M.D. Norris; J. Smith; K. Tanabe; P. Tobin; C. Flemming; G.L. Scheffer; P Wielinga; S.L. Cohn; W.B. London; G.M. Marshall; JD Allen; M. Haber

doi:10.1158/1535-7163.MCT-04-0161

Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro

M.D. Norris, J. Smith, K. Tanabe, P. Tobin, C. Flemming, G.L. Scheffer, P Wielinga, S.L. Cohn, W.B. London, G.M. Marshall, JD Allen, M. Haber

Amsterdam UMC

Research output: Contribution to journal › Article › Academic › peer-review

116 Citations (Scopus)

Original language	English
Pages (from-to)	547-553
Journal	Molecular cancer therapeutics
Volume	4
Issue number	4
DOIs	https://doi.org/10.1158/1535-7163.MCT-04-0161
Publication status	Published - 2005

Access to Document

10.1158/1535-7163.MCT-04-0161

Cite this

Norris, M. D., Smith, J., Tanabe, K., Tobin, P., Flemming, C., Scheffer, G. L., Wielinga, P., Cohn, S. L., London, W. B., Marshall, G. M., Allen, JD., & Haber, M. (2005). Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro. Molecular cancer therapeutics, 4(4), 547-553. https://doi.org/10.1158/1535-7163.MCT-04-0161

@article{94cdf7e015aa4fdfb462b37611cae9bd,

title = "Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro",

author = "M.D. Norris and J. Smith and K. Tanabe and P. Tobin and C. Flemming and G.L. Scheffer and P Wielinga and S.L. Cohn and W.B. London and G.M. Marshall and JD Allen and M. Haber",

year = "2005",

doi = "10.1158/1535-7163.MCT-04-0161",

language = "English",

volume = "4",

pages = "547--553",

journal = "Molecular cancer therapeutics",

issn = "1535-7163",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

Norris, MD, Smith, J, Tanabe, K, Tobin, P, Flemming, C, Scheffer, GL, Wielinga, P, Cohn, SL, London, WB, Marshall, GM, Allen, JD & Haber, M 2005, 'Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro', Molecular cancer therapeutics, vol. 4, no. 4, pp. 547-553. https://doi.org/10.1158/1535-7163.MCT-04-0161

TY - JOUR

T1 - Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro

AU - Norris, M.D.

AU - Smith, J.

AU - Tanabe, K.

AU - Tobin, P.

AU - Flemming, C.

AU - Scheffer, G.L.

AU - Wielinga, P

AU - Cohn, S.L.

AU - London, W.B.

AU - Marshall, G.M.

AU - Allen, JD

AU - Haber, M.

PY - 2005

Y1 - 2005

U2 - 10.1158/1535-7163.MCT-04-0161

DO - 10.1158/1535-7163.MCT-04-0161

M3 - Article

SN - 1535-7163

VL - 4

SP - 547

EP - 553

JO - Molecular cancer therapeutics

JF - Molecular cancer therapeutics

IS - 4

ER -